<unk>  (trade name Bevyxxa) is an oral anticoagulant drug which acts as a direct factor Xa inhibitor.<unk>  is FDA approved for venous thrombosis prevention in adults hospitalized for an acute illness who are at risk for thromboembolic complications. Compared to other directly acting oral anticoagulants<unk>  has relatively low renal excretion and is not metabolized by CYP3A4.
Betrixaban
Rivaroxaban
Apixaban
Enoxaparin sodium
Dabigatran
Edoxaban
Palladin
Ticlopidine